Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study

Diabetes Care

Volumn 34, Issue 6, 2011, Pages 1329-1336

  Huang, Elbert S ^a   Liu, Jennifer Y ^b   Moffet, Howard H ^b   John, Priya M ^a   Karter, Andrew J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; CALIFORNIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052000282     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2377     Document Type: Article

References (25)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
2. Huang E.S., Zhang Q., Gandra N., Chin M.H., Meltzer D.O. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008;149:11-19
3. Greenfield S., Billimek J., Pellegrini F., et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study. Ann Intern Med 2009;151:854-860
4. Gerstein H.C., Miller M.E., Byington R.P., et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)
5. Patel A., MacMahon S., Chalmers J., et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
6. Duckworth W., Abraira C., Moritz T., et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
7. Stratton I.M., Adler A.I., Neil H.A.W., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-412 (Pubitemid 30609442)
8. Currie C.J., Peters J.R., Tynan A., et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010;375:481-489
9. Rodbard H.W., Blonde L., Braithwaite S.S., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;(Suppl. 1):1-68
10. Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A.; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51(Suppl. 5 Guidelines):S265-S280
11. Karter A.J., Parker M.M., Moffet H.H., et al. Missed appointments and poor glycemic control: An opportunity to identify high-risk diabetic patients. Med Care 2004;42:110-115
12. Karter A.J., Ferrara A., Liu J.Y., Moffet H.H., Ackerson L.M., Selby J.V. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527 (Pubitemid 34517197)
13. Iribarren C., Karter A.J., Go A.S., et al. Glycemic control and Heart failure among adult patients with diabetes. Circulation 2001;103:2668-2673 (Pubitemid 32538780)
14. Karter A.J., Ackerson L.M., Darbinian J.A., et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9 (Pubitemid 32635255)
15. Schafer J.L. Multiple imputation: A primer. Stat Methods Med Res 1999;8:3-15 (Pubitemid 29222784)
16. Katakura M., Naka M., Kondo T., et al. Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects: Nagano Study. Diabetes Care 2003;26:638-644 (Pubitemid 36929320)
17. Blaum C.S., Volpato S., Cappola A.R., et al. Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I. Diabet Med 2005;22:543-550 (Pubitemid 40593128)
18. Nelson K.M., Boyko E.J., Koepsell T. Allcause mortality risk among a national sample of individuals with diabetes. Diabetes Care 2010;33:2360-2364
19. Riddle M.C., Ambrosius W.T., Brillon D.J., et al.; Action to Control Cardiovascular Risk in Diabetes Investigators. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010;33:983-990
20. Kim T.N., Park M.S., Yang S.J., et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS).Diabetes Care 2010;33:1497-1499
21. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
22. Nathan D.M., Singer D.E., Godine J.E., Perlmuter L.C. Non-insulin-dependent diabetes in older patients. Complications and risk factors. Am J Med 1986;81:837-842
23. Bertoni A.G., Kirk J.K., Goff D.C. Jr, Wagenknecht L.E. Excess mortality related to diabetes mellitus in elderly Medicare beneficiaries. Ann Epidemiol 2004;14:362-367 (Pubitemid 38737329)
24. Dekker F.W., De Mutsert R., Van Dijk P.C., Zoccali C., Jager K.J. Survival analysis: Time-dependent effects and time-varying risk factors. Kidney Int 2008;74:994-997
25. Huang E.S., Brown S.E., Ewigman B.G., Foley E.C., Meltzer D.O. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007;30:2478-2483 (Pubitemid 47547775)